Aperio Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Aperio Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-994	Closed	-$2K	–	2854
2019 Q2	$2K	Buy	+994	New	+$1.6K	﹤0.01%	2949
2017 Q4	–	Sell	-11,161	Closed	-$15K	–	2262
2017 Q3	$15K	Sell	11,161 -15,235	-58%	-$18.9K	﹤0.01%	2217
2017 Q2	$41K	Hold	26,396	–	–	﹤0.01%	2200
2017 Q1	$85K	Buy	26,396 +1,476	+6%	+$3.63K	﹤0.01%	2118
2016 Q4	$34K	Buy	24,920 +13,329	+115%	+$17.4K	﹤0.01%	2111
2016 Q3	$18K	Buy	+11,591	New	+$17.8K	﹤0.01%	2055
2016 Q2	–	Sell	-11,194	Closed	-$59K	–	2043
2016 Q1	$59K	Buy	+11,194	New	+$68.5K	﹤0.01%	1996
2015 Q3	–	Sell	-12,635	Closed	-$138K	–	2021
2015 Q2	$138K	Buy	+12,635	New	+$162K	﹤0.01%	1924

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Aperio Group's INFI Position: Q3 2019 in Review

Aperio Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2019, closing a stake of 994 shares — an estimated $2K sold.

Aperio Group first reported a position in INFI in Q2 2015 and held it in 8 quarters. The position peaked at $138K in Q2 2015. 51 funds tracked by Wall St. Rank hold INFI as of Q3 2019.

Aperio Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 994 Infinity Pharmaceuticals, Inc. shares in Q3 2019, an estimated $2K.
Aperio Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
Aperio Group's Infinity Pharmaceuticals, Inc. position peaked at $138K in Q2 2015.
51 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.